MX366805B - Uso de sulfato de zinc coceth como un agente antibacteriano en contra de propionibacterium acnes. - Google Patents

Uso de sulfato de zinc coceth como un agente antibacteriano en contra de propionibacterium acnes.

Info

Publication number
MX366805B
MX366805B MX2015000275A MX2015000275A MX366805B MX 366805 B MX366805 B MX 366805B MX 2015000275 A MX2015000275 A MX 2015000275A MX 2015000275 A MX2015000275 A MX 2015000275A MX 366805 B MX366805 B MX 366805B
Authority
MX
Mexico
Prior art keywords
antibacterial agent
propionibacterium acnes
agent against
coceth sulfate
against propionibacterium
Prior art date
Application number
MX2015000275A
Other languages
English (en)
Other versions
MX2015000275A (es
Inventor
Baco David
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of MX2015000275A publication Critical patent/MX2015000275A/es
Publication of MX366805B publication Critical patent/MX366805B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)

Abstract

La invención se refiere a sulfato de zinc coceth para el uso del mismo como un agente antibacterial para el tratamiento de trastornos de la piel asociados con Propionibacterium acnes.
MX2015000275A 2012-07-09 2013-07-08 Uso de sulfato de zinc coceth como un agente antibacteriano en contra de propionibacterium acnes. MX366805B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1256606A FR2992859B1 (fr) 2012-07-09 2012-07-09 Utilisation de coceth sulfate de zinc comme agent antibacterien vis a vis de propionibacterium acnes
PCT/EP2013/064391 WO2014009315A2 (fr) 2012-07-09 2013-07-08 Utilisation de coceth sulfate de zinc comme agent antibacterien vis a vis de propionibacterium acnes

Publications (2)

Publication Number Publication Date
MX2015000275A MX2015000275A (es) 2015-07-21
MX366805B true MX366805B (es) 2019-07-24

Family

ID=46826804

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015000275A MX366805B (es) 2012-07-09 2013-07-08 Uso de sulfato de zinc coceth como un agente antibacteriano en contra de propionibacterium acnes.

Country Status (18)

Country Link
US (1) US9855205B2 (es)
EP (1) EP2874711B1 (es)
JP (1) JP2015522053A (es)
KR (1) KR102209331B1 (es)
CN (1) CN104602764B (es)
AR (1) AR091705A1 (es)
AU (1) AU2013289294B2 (es)
BR (1) BR112015000186B1 (es)
CA (1) CA2878633C (es)
ES (1) ES2727967T3 (es)
FR (1) FR2992859B1 (es)
HK (1) HK1209675A1 (es)
IN (1) IN2015DN00710A (es)
MX (1) MX366805B (es)
PT (1) PT2874711T (es)
RU (1) RU2638799C2 (es)
TW (1) TWI645849B (es)
WO (1) WO2014009315A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2526784A (en) * 2014-05-26 2015-12-09 Skf Ab Micro electro optical mechanical system
CA2991917A1 (en) 2015-07-17 2017-01-26 Colgate-Palmolive Company Oral care compositions
CN112472617B (zh) * 2020-12-10 2022-07-01 南京泛成生物科技有限公司 一种脂肪酰烷基磺酸盐的自增稠体系、其制备方法及应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068055B1 (fr) * 1981-06-26 1986-04-02 P.F. Industrie Procédé d'obtention d'un extrait stable et désodorisé de sabal serrulatum antiprostatique
DE4241487C2 (de) * 1992-12-09 1996-07-25 Indena Spa Neue Extrakte von Cucurbita sp., Verfahren zu deren Herstellung und deren Verwendung in Arzneimitteln und in der Kosmetik
DE19733684A1 (de) * 1997-08-04 1999-02-11 Henkel Kgaa Konservierungsmittelsystem für Körperpflegemittel
US20020022660A1 (en) * 1998-01-20 2002-02-21 Hanuman B. Jampani Deep penetrating antimicrobial compositions
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
FR2783425B1 (fr) * 1998-09-17 2002-06-07 Fabre Pierre Dermo Cosmetique Extrait de myrte titre en myrtucommulone b', son procede de preparation et son application en dermatologie et en cosmetologie
IT1307262B1 (it) * 1999-07-20 2001-10-30 Zschimmer & Schwarz Italiana S Composizioni detergenti o cosmetiche comprendenti alchilsolfati e/oalchil(poli)etossisolfati di zinco quali agenti tensioattivi e
JP4044274B2 (ja) * 2000-08-01 2008-02-06 株式会社ノエビア 微生物性リパーゼ阻害剤、及びこれを含有するニキビ用皮膚外用剤並びにフケ用皮膚外用剤
DE10232774B4 (de) * 2002-07-18 2004-07-15 Cognis Deutschland Gmbh & Co. Kg Kosmetische Zubereitungen mit antibakteriellen Eigenschaften
ITMI20032286A1 (it) * 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento di dermatiti atopiche di stati allergici cutanei e dell'acne
JP5132154B2 (ja) * 2004-01-20 2013-01-30 ハンツマン ペトロケミカル エルエルシー 新規なアシルアルキルイセチオン酸エステルおよび消費者製品における応用
US8236357B2 (en) * 2006-12-13 2012-08-07 Aseptix Research B.V. Mild composition for skin disinfection
GB0722550D0 (en) * 2007-11-16 2007-12-27 Innospec Ltd Composition
ITTO20070857A1 (it) * 2007-11-28 2009-05-29 Cristina Capelli Composizione conservante, metodo per la sua preparazione, suo uso e sua formulazione
US8362077B2 (en) * 2008-08-15 2013-01-29 Pibed Limited Chemical compositions for skin care emulsions and heavy duty hand cleansers
US20100226948A1 (en) * 2009-03-05 2010-09-09 Medicis Pharmaceutical Corporation Methods and compositions for treating acne
CN102639107A (zh) * 2009-08-03 2012-08-15 因诺斯佩克有限公司 组合物
FR2954124B1 (fr) 2009-12-18 2012-04-06 Fabre Pierre Dermo Cosmetique Utilisation du 2,3-dihydroxypropyl dodecanoate pour le traitement de la seborrhee
IT1400707B1 (it) * 2010-06-25 2013-06-28 Farmaceutici Dott Ciccarelli S P A Uso di composti antibatterici per l'igiene del cavo orale
FR2966364B1 (fr) * 2010-10-22 2013-05-24 Oreal Composition cosmetique comprenant de l'aloe vera et un derive d'acide isethionique
FR2980691B1 (fr) * 2011-09-30 2014-03-14 Galderma Sa Composition de lavage

Also Published As

Publication number Publication date
CN104602764A (zh) 2015-05-06
US20150196474A1 (en) 2015-07-16
AU2013289294B2 (en) 2017-11-30
MX2015000275A (es) 2015-07-21
BR112015000186B1 (pt) 2019-09-17
EP2874711A2 (fr) 2015-05-27
AU2013289294A1 (en) 2015-02-19
ES2727967T3 (es) 2019-10-21
BR112015000186A2 (pt) 2017-06-27
JP2015522053A (ja) 2015-08-03
TW201408289A (zh) 2014-03-01
FR2992859B1 (fr) 2014-10-03
FR2992859A1 (fr) 2014-01-10
KR102209331B1 (ko) 2021-01-28
CN104602764B (zh) 2017-03-29
RU2015104101A (ru) 2016-08-27
TWI645849B (zh) 2019-01-01
US9855205B2 (en) 2018-01-02
AR091705A1 (es) 2015-02-25
PT2874711T (pt) 2019-06-18
CA2878633C (fr) 2020-08-18
CA2878633A1 (fr) 2014-01-16
KR20150036378A (ko) 2015-04-07
HK1209675A1 (en) 2016-04-08
WO2014009315A2 (fr) 2014-01-16
IN2015DN00710A (es) 2015-06-26
EP2874711B1 (fr) 2019-03-13
RU2638799C2 (ru) 2017-12-15
WO2014009315A3 (fr) 2014-10-23

Similar Documents

Publication Publication Date Title
MX2016005556A (es) Compuestos agonistas duales de gip-glp-1 y procedimientos.
MX2015011897A (es) Profarmacos de fumaratos y su uso en el tratamiento de diferentes enfermedades.
JOP20140141B1 (ar) استخدام 3،2- ثنائي هيدروإيميدازول-[2،1-c] كونازولينات مستبدلة لمعالجة الاورام الليمفاوية
PL3082831T3 (pl) Kompozycje oparte na metylocyklodekstrynach do leczenia i/lub zapobiegania chorobom poprzez podwyższenie poziomu cholesterolu HDL
EP2872151A4 (en) ACELLULAR PRO-TOLEROGENIC COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES
HK1220324A1 (zh) 用於治療血管緊張素相關疾病的方法、化合物和組合物
PH12016501702B1 (en) Pyrazole amide derivative
IN2015DN00438A (es)
NZ710444A (en) Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
EP3065768A4 (en) Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation
IL259486A (en) Substances for the treatment of diseases associated with unwanted cell proliferation
MX365403B (es) Peptidos y metodos para usarlos.
SG11201503231YA (en) METHODS OF TREATING <i>S. AUREUS</i>-ASSOCIATED DISEASES
MX2016006975A (es) Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias.
IN2015DN01524A (es)
MX2015009818A (es) Agonistas de receptores gamma activados por el proliferador de peroxisoma para el tratamiento de esclerosis multiple.
IL245164A0 (en) A biodegradable preparation containing antibacterial substances and its use for the treatment of lower back pain
MX2014015039A (es) Inhibidores de fbx03.
MX2015006337A (es) Metodos y composiciones para tratar enfermedades neurodegenerativas.
PL3041831T3 (pl) Postacie soli alfa-TEA: kompozycje i zastosowania do leczenia choroby
MX2015009277A (es) Formas de dosificacion y usos terapauticos de l-4-cloro quinurenina.
MX2013014488A (es) Metodos y composiciones para tratar el cancer cerebral.
IL243637A0 (en) PPAR-sparing compounds for the treatment of metabolic diseases
MX366805B (es) Uso de sulfato de zinc coceth como un agente antibacteriano en contra de propionibacterium acnes.
EP2910247A4 (en) COMPOSITIONS FOR PREVENTING OR TREATING ALLERGIC SKIN DISORDERS CONTAINING GPCR19 AGENTS AS ACTIVE INGREDIENTS

Legal Events

Date Code Title Description
FG Grant or registration